John M. Primrose
Impact in
- Hepatology top 0.2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 0.5%
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Surgical Treatments
Papers in
- Hepatology 36
- Hepatocellular Carcinoma Treatment and Prognosis 35
- Oncology 67
- Colorectal Cancer Treatments and Studies 27
- Pancreatic and Hepatic Oncology Research 19
- Colorectal Cancer Surgical Treatments 10
- Co-authors
- Graeme John Poston (3 shared papers)Jill L Colquitt (2 shared papers)M.R. Rees (3 shared papers)O. James Garden (1 shared paper)Mohammad Abu Hilal (15 shared papers)A C Gough (6 shared papers)Juan W. Valle (8 shared papers)Julien Edeline (3 shared papers)
- Journals
- British Journal of Cancer (23 papers)British journal of surgery (16 papers)HPB (13 papers)Gut (11 papers)Annals of Oncology (9 papers)
- Partner nations
- United KingdomNetherlandsItaly
In The Last Decade
John M. Primrose
184 papers receiving 11.0k citations
John M. Primrose's Hit Papers
Peers
Comparison fields: 5 of 153
- Hepatology 2.8k
- Oncology 3.5k
- Surgery 4.2k
- Cancer Research 1.0k
- Pulmonary and Respiratory Medicine 1.8k
Countries citing papers authored by John M. Primrose
This map shows the geographic impact of John M. Primrose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Primrose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Primrose more than expected).
Fields of papers citing papers by John M. Primrose
This network shows the impact of papers produced by John M. Primrose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Primrose. The network helps show where John M. Primrose may publish in the future.
Co-authors
The 25 scholars most cited alongside John M. Primrose, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 198 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study Hit paper breakdown → | 2019 | 921 |
| 2 | Surgical resection of hepatic metastases from colorectal cancer: A systematic review of published studies Hit paper breakdown → | 2006 | 706 |
| 3 | The Southampton Consensus Guidelines for Laparoscopic Liver Surgery Hit paper breakdown → | 2017 | 551 |
| 4 | Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors Hit paper breakdown → | 2012 | 539 |
| 5 | Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial Hit paper breakdown → | 2017 | 406 |
| 6 | Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up Hit paper breakdown → | 2022 | 403 |
| 7 | Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline Hit paper breakdown → | 2019 | 336 |
| 8 | 2013 | 333 | |
| 9 | Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial Hit paper breakdown → | 2014 | 327 |
| 10 | 1994 | 319 | |
| 11 | 1999 | 221 | |
| 12 | 2005 | 214 | |
| 13 | 2017 | 213 | |
| 14 | 1993 | 197 | |
| 15 | Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer-term studies. | 1998 | 186 |
| 16 | 2015 | 176 | |
| 17 | 2003 | 174 | |
| 18 | Hereditary desmoid disease due to a frameshift mutation at codon 1924 of the APC gene. | 1996 | 162 |
| 19 | 1987 | 159 | |
| 20 | 2018 | 157 |
About John M. Primrose
John M. Primrose is a scholar working on Hepatology, Oncology, Surgery, Pulmonary and Respiratory Medicine and Gastroenterology, having authored 198 papers that have together received 11.4k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (35 papers), Colorectal Cancer Treatments and Studies (27 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (19 papers), Pancreatic and Hepatic Oncology Research (19 papers), Helicobacter pylori-related gastroenterology studies (17 papers), Gastric Cancer Management and Outcomes (13 papers), Neuroendocrine Tumor Research Advances (11 papers) and Colorectal Cancer Surgical Treatments (10 papers). The work is most often cited by research in Hepatology (2.8k citations), Oncology (3.5k citations), Surgery (4.2k citations), Cancer Research (1.0k citations) and Pulmonary and Respiratory Medicine (1.8k citations). John M. Primrose has collaborated with scholars based in United Kingdom, Netherlands and Italy. Frequent co-authors include Graeme John Poston, Jill L Colquitt, M.R. Rees, O. James Garden, Mohammad Abu Hilal, A C Gough, Juan W. Valle, Julien Edeline, John Bridgewater and Jean E. Crabtree. Their work appears in journals such as British Journal of Cancer, British journal of surgery, HPB, Gut and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.